Expression of functional CD40 antigen on Reed-Sternberg cells and Hodgkin's disease cell lines

Blood

Volumn 85, Issue 3, 1995, Pages 780-789

  Carbone, Antonino ^a   Gloghini, Annunziata ^a   Gattei, Valter ^a   Aldinucci, Donatella ^a   Degan, Massimo ^a   De Paoli, Paolo ^a   Zagonel, Vittorina ^a   Pinto, Antonio ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; INTERLEUKIN 9;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER CLASSIFICATION; CELL ADHESION; COLONY FORMATION; CONTROLLED STUDY; FLOW CYTOMETRY; HISTOLOGY; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOMA CELL LINE; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; NORTHERN BLOTTING; PRIORITY JOURNAL; REED STERNBERG CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

EID: 0028908965     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v85.3.780.bloodjournal853780     Document Type: Article

References (59)

1. Stamenkovich I, Clark EA, Seed B: A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J 8:1403, 1989
2. Dörken B, Möller P, Pezzutto A, Schwartz-Albiez R, Moldenhauer G: B-cell antigens: CD40, in Knapp W, Dörken B, Gilks WR, Rieber EP, Schmidt RE, Stein H, Von Dem Borne AEGKr (eds): Leucocyte Typing IV. White Cell Differentiation Antigens. Oxford, UK, Oxford University, 1989, p 90
3. Uckun FM, Gajl-Peczalska K, Myers DE, Jaszcz W, Haissig S, Ledbetter JA: Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells. Blood 76:2449, 1990
4. Galy AHM, Spits H: CD40 is functionally expressed on human thymic epithelial cells. J Immunol 1149:775, 1992
5. Schriever F, Freedman AS, Freeman G, Messner E, Lee G, Daley J, Nadler LM: Isolated human follicular dendritic cells display a unique antigenic phenotype. J Exp Med 169:2043, 1989
6. Law C-L, Wörmann B, LeBien TW: Analysis of expression and function of CD40 on normal and leukemic human B cell precursors. Leukemia 4:732, 1990
7. Smith GA, Farrah T, Goodwin RG: The TNF receptor super-family of cellular and viral proteins: Activation, costimulation, and death. Cell 76:959, 1994
8. Dürkop H, Latza U, Hummel M, Eithelbach F, Seed B, Stein H: Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68:421, 1992
9. Clark EA, Ledbetter JA: Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc Natl Acad Sci USA 83:4494, 1986
10. Paulie S, Rosén A, Ehlin-Henriksson B, Braesch-Andersen S, Jacobson E, Koho H, Perlmann P: The human B lymphocyte and carcinoma antigen, CDw40, is a phosphoprotein involved in growth signal transduction. J Immunol 142:590, 1989
11. Banchereau J, de Paoli P, Vallé A, Garcia E, Rousset F: Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251:70, 1991
12. Spriggs MK, Armitage RJ, Strockbine L, Clifford KN, Macduff BM, Sato TA, Maliszewski CR, Fanslow WC: Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J Exp Med 176:1543, 1992
13. Barrett TB, Shu G, Clark EA: CD40 signaling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells. J Immunol 146:1722, 1991
14. Hollenbaugh D, Grosmarie LS, Kullas CD, Chalupny NJ, Braesch-Andersen S, Noelle RJ, Stamenkovic I, Ledbetter JA, Aruffo A: The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: Expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 11:4313, 1992
15. Lane P, Traunecker A, Hubele S, Inui S, Lanzavecchia A, Gray D: Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes. Eur J Immunol 22:2573, 1992
16. Liu Y-J, Mason DY, Johnson GD, Abbot S, Gregory CD, Hardie DL, Gordon J, MacLennan ICM: Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol 21:1905, 1991
17. Westendorf JJ, Ahmann GJ, Armitage RJ, Spriggs MK, Lust JA, Greipp PR, Katzmann JA, Jelinek DF: CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line. J Immunol 152:117, 1994
18. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848, 1985
19. Ree HJ, Neiman RS, Martin AW, Dallenbach F, Stein H. Paraffin section markers for Reed-Sternberg cells: A comparative study of peanut agglutinin, Leu-M1, LN-2, and Ber-H2. Cancer 63:2030, 1989
20. Frizzera G: The distinction of Hodgkin's disease from anaplastic large cell lymphoma. Semin Diagn Pathol 9:291, 1992
21. Stein H: Ki-1 anaplastic large cell lymphoma: Is it a discrete entity? Leuk Lymphoma 10:81, 1993 (suppl)
22. Kadin ME: Primary Ki-1-positive anaplastic large cell lymphoma: A distinct clinicopathologic entity. Annals Oncol: 5:25, 1994 (suppl 1)
23. Agnarsson BA, Kadin ME: Ki-1 positive large cell lymphoma. A morphologic and immunologic study of 19 cases. Am J Surg Pathol 12:264, 1988
24. +) lymphomas. Virchows Arch A Pathol Anat Histopathol 420:527, 1992
25. Carbone A, Gloghini A, Volpe R: Immunohistochemistry of Hodgkin's and non-Hodgkin's lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas. Cancer 70:2691, 1992
26. + anaplastic large cell lymphomas. Blood 83:785, 1994
27. Della Croce DR, Imam A, Brynes RK, Nathwani BN, Taylor CR: Anti-BLA.36 monoclonal antibody shows reactivity with Hodgkin's cells and B lymphocytes in frozen and paraffin-embedded tissues. Hematol Oncol 9:103, 1991
28. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, Macdonald S, Pulford KAF, Stein H, Mason DY: Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219, 1984
29. Drexler HG: Recent results on the biology of Hodgkin and Reed-Sternberg cells. II. Continuous cell lines. Leuk Lymphoma 9:1, 1993
30. Fischer P, Nacheva E, Mason DY, Sherrington PD, Hoyle C, Hayhoe FGJ, Karpas A: A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2:5 translocation and rearrangement of the T-cell receptor β-chain gene. Blood 72:234, 1988
31. Th'ng KH, Garewal G, Kearney L, Rassool F, Melo JV, White H, Catovsky D, Foroni L, Luzzato L, Goldman JM: Establishment and characterization of three new malignant lymphoid cell lines. Int J Cancer 39:89, 1987
32. Muirhead KA, Schmitt TC, Muirhead AR: Determination of linear fluorescence intensities from flow cytometric data accumulated with logarithmic amplifiers. Cytometry 3:251, 1983
33. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
34. Armitage RJ, Tough TW, Macduff BM, Fanslow WC, Spriggs MK, Ramsdell F, Alderson MR: CD40 ligand is a T cell growth factor. Eur J Immunol 23:2326, 1993
35. Pinto A, Aldinucci D, Gattei V, Zagonel V, Tortora G, Budillon A, Cho-Chung YS: Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3′,5′-cyclic monophosphate. Proc Natl Acad Sci USA 89:8884, 1992
36. Gruss H-J, Brach MA, Drexler HG, Bross KJ, Herrmann F: Interleukin 9 is expressed by primary and cultured Hodgkin and Reed-Sternberg cells. Cancer Res 52:1026, 1992
37. Carbone A, Gloghini A, Volpe R, Attadia V, Gattei V, Zagonel V, Pinto A: Follicular lymphoma of compartmentalized small cleaved center cells and mantle zone lymphocytes. Evidence for a common derivation. Am J Clin Pathol 98:437, 1992
38. Sanders ME, Makgoba MW, Sussman EH, Luce GEG, Cossman J, Shaw S: Molecular pathways of adhesion in spontaneous rosetting of T-lymphocytes to the Hodgkin's cell line L-428. Cancer Res 48:37, 1988
39. Drexler HG: Recent results on the biology of Hodgkin and Reed-Sternberg cells. I. Biopsy material. Leuk Lymphoma 8:283, 1992
40. Chittal SM, Caverivière P, Schwarting R, Gerdes J, Al Saati T, Rigal-Huguet F, Stein H, Delsol G:. Monoclonal antibodies in the diagnosis of Hodgkin's disease: The search for a rational panel. Am J Surg Pathol 12:9, 1988
41. Pinkus GS, Said JW: Hodgkin's disease, lymphocyte predominance type, nodular - Further evidence for a B-cell derivation. L& H variants of Reed-Sternberg cells express L26, a pan B-cell marker. Am J Pathol 133:211, 1988
42. Pinkus GS, Thomas P, Said JW: Leu-M1 - A marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues. Am J Pathol 119:244, 1985
43. Carbone A, Poletti A, Manconi R, Volpe R, Betta PG: Reliability of anti-Leu-M1 immunostaining in Hodgkin's disease. Arch Pathol Lab Med 110:465, 1986
44. Carbone A, Manconi R, Poletti A, Sulfaro S, Menin A, Tirelli U, Betta PG, Volpe R: Reed-Sternberg cells and their cell microenvironment in Hodgkin's disease with reference to macrophage-histiocytes and interdigitating reticulum cells. Cancer 60:2662, 1987
45. Dorken B, Moldenhauer G: Phenotypic analysis of the third international workshop B-cell panel, in MCMichael AJ, Beverley PCL, Cobbold S, Crumpton MJ, Gilks W, Gotch FM, Hogg N, Horton M, Ling N, MacLennana ICM, Mason DY, Milstein C, Spiegelhalter D, Waldmann H (eds): Leucocyte Typing III. White Cell Differentiation Antigens, Oxford, Oxford University, 1987, p 369
46. Pezzutto A, Behm F, Callard RE, Clark EA, Genetet N, Goodhal AH, Gramatzki M, Hostoffer P, Cooper MD, Heldrup J, Campana D, Janossy G, Ling NR, Ledbetter JA, Ludwig WD, Pilkington GR, Steel CM, Tedder TF, Wijdenes J, Racadoet E, Dörken B: Flow cytometry analysis of the B-cell blind panel: joint report, in Knapp W, Dörken B, Gilks WR, Rieber EP, Schmidt RE, Stein H, Von Dem Borne AEGKr (eds): Leucocyte Typing IV. White Cell Differentiation Antigens, Oxford, UK, Oxford University, 1989, p 165
47. Johnson PWM, Watt SM, Betts DR, Davies D, Jordan S, Norton AJ, Lister TA: Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40/stromal cell system. Blood 82:1848, 1993
48. Funakoshi S, Longo DL, Beckwith M, Conley DK, Tsafaty G, Tsafaty I, Armitage RJ, Fanslow W. Spriggs MK, Murphy WJ: Inhibition of human B cell lymphoma growth by CD40 stimulation. Blood 83:2787, 1994
49. Rosso R, Paulli M, Magrini U, Kindl S, Boveri E, Volpato G, Poggi S, Baglioni P, Pileri S: Anaplastic large cell lymphoma, CD30/Ki-1 positive, expressing the CD15/LeuM1 antigen: Immunohistochemical and morhological relationships to Hodgkin's disease. Virchows Arch A Pathol Anat Histopathol 416:229, 1990
50. O'Grady JT, Stewart S, Lowrey J, Howie SE, Krajewski AS: CD40 expression in Hodgkin's disease. Am J Pathol 144:21, 1994
51. Callard RE, Armitage RJ, Fanslow C, Spriggs MK: CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol Today 14:559, 1993
52. + T cells that induces contact-dependent B cell differentiation (help). J Exp Med 175:1091, 1992
53. Poppema S: The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease. Am J Pathol 135:351, 1989
54. + T cells, genomic organization, and comparison with the mouse gene. J Immunol 144:4235, 1990
55. Merz H, Houssiau FA, Orsheschek K, Renauld JC, Fliedner A, Herin M, Noel H, Kadin M, Mueller-Hermelink HK, Van Snick J, Feller AC: Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood 78:1311, 1991
56. Delabie J, Ceuppens JL, Vandeberghe P, de Boer M, Coorevits L, De Wolf-Peters C: The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines. Blood 82:2845, 1993
57. Munro JM, Freedman AS, Aster JC, Gribben JG, Lee NC, Rhynhart KK, Bancherau J, Nadler LM: In vivo expression of the B7 costimulatory molecule by subsets of antigen presenting cells and the malignant cells of Hodgkin's disease. Blood 83:793, 1994
58. Azuma M, Dalsuke I, Yagita H, Okumura K, Phillips JH, Lanier L, Somoza C: B70 antigen is a second ligand for CTLA-4 and CD28. Nature 366:76, 1993
59. Clark EA, Ledbetter JA: How B and T cells talk to each other. Nature 367:425, 1994